Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382733 · ClinicalTrials.gov registry record · Phase 1
Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
A Phase 1 study, sponsored by Accelerated Community Oncology Research Network.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT00382733 is a Phase 1 study that has completed, run by Accelerated Community Oncology Research Network. The registered enrollment target is 26 participants.
The verdict
NCT00382733, a Phase 1 study, has completed, sponsored by Accelerated Community Oncology Research Network.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of oral topotecan and how well the chemotherapy is tolerated (any side effects) when it is given in different dose levels. The study will also collect information on how the medication is being broken down and absorbed in the body and how quality of life is affected during treatment.
Interventions
- DRUG Oral Topotecan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382733
The ClinicalTrials.gov registry entry for NCT00382733 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Accelerated Community Oncology Research Network, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral Topotecan is the first listed.
NCT00382733 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382733 about?
NCT00382733 is a clinical study titled "Oral Topotecan to Treat Recurrent or Persistent Solid Tumors". The purpose of this study is to evaluate the effectiveness of oral topotecan and how well the chemotherapy is tolerated (any side effects) when it is given in different dose levels. The study will also collect information on how the medication is being broken down and absorbed in the body and how qu...
What is the current status of trial NCT00382733?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2006-11. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00382733?
The interventions under investigation include: Oral Topotecan (DRUG).
Who is sponsoring clinical trial NCT00382733?
This trial is sponsored by Accelerated Community Oncology Research Network, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.